SCHEMBL756342

SCHEMBL756342

CCOCn1nc(OC2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 1/20 0.45
HRH3 Q9Y5N1 2/20 0.44
LMNA P02545 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ABL1 P00519 1/20 0.43
RET P07949 1/20 0.42
GAA P10253 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
SMO Q99835 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
CYP3A4 P08684 1/20 0.40
LIPE Q05469 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759929 0.83 SMN1; SMN2 (0.45) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL12667671 0.73 KDM4E (0.51) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL15745703 0.73 HRH3 (0.45) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL19892721 0.72 KDM4E (0.57) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL756547 0.72 HRH3 (0.44) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL383384 0.71 KDM4E (0.49) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL12371239 0.71 KDM4E (0.49) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL761742 0.71 HRH3 (0.48) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL755929 0.70 SMN1; SMN2 (0.58) SMN1; SMN2HPGDHRH3LMNAKDM4E
SCHEMBL12371186 0.70 HCRTR1 (0.41) SMN1; SMN2HPGDHRH3LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2050745-B1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA AGRITECHNO CO LTD (JP) 2012-03-21 EP disclosed
US-7994094-B2 N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA AGRITECHNO CO., LTD. (JP) 2011-08-09 US disclosed
US-7994094-B2 N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA AGRITECHNO CO., LTD. (JP) 2011-08-09 US disclosed
US-7994094-B2 N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA AGRITECHNO CO., LTD. (JP) 2011-08-09 US disclosed
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA CHEMICAL CO., LTD. (JP) 2010-06-03 US disclosed
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA CHEMICAL CO., LTD. (JP) 2010-06-03 US disclosed
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA CHEMICAL CO., LTD. (JP) 2010-06-03 US disclosed
EP-2050745-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT Otsuka Chemical Co., Ltd. (JP) 2009-04-22 EP disclosed
EP-2050745-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT Otsuka Chemical Co., Ltd. (JP) 2009-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT HRH4, NOX4, PRDX4 SMN1; SMN2 2257/4885HPGD 2035/4885HRH3 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.